Characterization of C3dg binding to a recess formed between short consensus repeats 1 and 2 of complement receptor type 2 (CR2; CD21).
about
The crystal structure of human CD21: Implications for Epstein-Barr virus and C3d binding.B-cell activity in children with malariaInfectious Epstein-Barr virus lacking major glycoprotein BLLF1 (gp350/220) demonstrates the existence of additional viral ligands.Control of Epstein-Barr virus infection in vitro by T helper cells specific for virion glycoproteins.B cells of HIV-1-infected patients bind virions through CD21-complement interactions and transmit infectious virus to activated T cells.Epstein-Barr virus infection of human astrocyte cell lines.Detachment of human immunodeficiency virus type 1 from germinal centers by blocking complement receptor type 2.Spontaneous complement activation on human B cells results in localized membrane depolarization and the clustering of complement receptor type 2 and C3 fragments.CR2-mediated activation of the complement alternative pathway results in formation of membrane attack complexes on human B lymphocytes.
P2860
Q27639376-E00EC96E-9ED9-4CB9-9E6A-DD0C017B19AAQ30427395-F34C044F-1E61-42F3-B77B-8F7CD0A17E15Q33603682-1AD78047-53AD-453C-8223-51D1FC850FB2Q36228567-9A400688-9CE4-4EA5-BDA6-4E3E3DCCEDD0Q36368837-76E7781C-8A9E-4E8B-BEF2-8FDF25781DB4Q39551082-95DAF418-A246-4D6F-A615-D1636F0E66AAQ39593041-23B61BAA-C9F4-4411-B43E-CF28CDADD182Q43279104-32FD8D27-2B3E-4E86-AEC0-AAE99CB5B71BQ43920731-34E92EFD-B9DA-44FF-A956-E8E4E063CE51
P2860
Characterization of C3dg binding to a recess formed between short consensus repeats 1 and 2 of complement receptor type 2 (CR2; CD21).
description
1998 nî lūn-bûn
@nan
1998 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
name
Characterization of C3dg bindi ...... t receptor type 2 (CR2; CD21).
@ast
Characterization of C3dg bindi ...... t receptor type 2 (CR2; CD21).
@en
type
label
Characterization of C3dg bindi ...... t receptor type 2 (CR2; CD21).
@ast
Characterization of C3dg bindi ...... t receptor type 2 (CR2; CD21).
@en
prefLabel
Characterization of C3dg bindi ...... t receptor type 2 (CR2; CD21).
@ast
Characterization of C3dg bindi ...... t receptor type 2 (CR2; CD21).
@en
P2093
P1476
Characterization of C3dg bindi ...... nt receptor type 2 (CR2; CD21)
@en
P2093
Dierich MP
Prodinger WM
Schwendinger MG
P304
P407
P577
1998-11-01T00:00:00Z